Press Release: Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review

https://ift.tt/lf4yxn5

Dupixent^® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review

from Sanofi - Aventis Groupe https://ift.tt/24xDg9L
via IFTTT

" May good health envelop you, spurring a quick recovery. .. "

from health care https://ift.tt/An3tE8B
via IFTTT https://ift.tt/X2m1z8l

SHARE

Milan Tomic

Hi. I’m Designer of Blog Magic. I’m CEO/Founder of ThemeXpose. I’m Creative Art Director, Web Designer, UI/UX Designer, Interaction Designer, Industrial Designer, Web Developer, Business Enthusiast, StartUp Enthusiast, Speaker, Writer and Photographer. Inspired to make things looks better.

• 
• 
• 
• 
•